Streptococcus B in pregnancy: to screen or not to screen?
BMJ 2012; 344 doi: https://doi.org/10.1136/bmj.e2803 (Published 18 April 2012) Cite this as: BMJ 2012;344:e2803- Margaret McCartney, general practitioner, Glasgow
- margaret{at}margaretmccartney.com
“Why won’t Britain act to prevent biggest killer of newborns? The £10 (€12; $16) test that could save babies from death,” read the Daily Mail’s headline last month.1 The tragic story of a baby called Ewan followed. He had died from group B streptococcus (GBS) eight hours after his birth. “‘It’s hard to put into words the pain we felt at losing our first child without ever having experienced the joy of getting to know him. It was like someone ripping out our hearts.’” The article went on, “We are one of the few developed countries not to screen for the infection. A third of women carry the bacterium, which is largely harmless to adults . . . One in 300 exposed to it will develop the infection.” The bottom line from the Mail was that “Spotting it early and treatment with antibiotics during labour or in the first few hours after childbirth can be life saving and …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.